SVMPharma Logo
  • Home
  • Our Services
    • Real World Evidence
    • Oncology Electronic Prescribing Records – RWE
    • RWE OUTCOMES
    • Global RWE
    • Additional Services
  • Resource Centre
  • About Us
  • Contact Us
Home / NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

NHS England endorses Real World Evidence for the Cancer Drugs Fund and NICE

thumbnail CDF NICE

23rd July NHS Board Paper Thumbnail

Posted in Blogs.

Post navigation

← Real World Evidence – Patient…
Real World Evidence Making Headlines →

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

  • 50% of real-world studies started in the last 3 years
  • RWE roundup – December 2018
  • Unique real-world study in diabetic macular oedema (DMO)
  • First real-world multicentre study of the use of inhaled aztreonam lysine for cystic fibrosis (CF)
  • DESERVE showed significant benefits in NHS healthcare savings

Archives

  • February 2019 (1)
  • January 2019 (1)
  • December 2018 (3)
  • November 2018 (2)
  • October 2018 (2)
  • September 2018 (1)
  • August 2018 (1)
  • April 2018 (1)
  • March 2018 (2)
  • February 2018 (2)
  • January 2018 (1)
  • November 2017 (2)
  • October 2017 (2)
  • September 2017 (3)
  • August 2017 (2)
  • July 2017 (3)
  • June 2017 (2)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (2)
  • February 2017 (2)
  • January 2017 (2)
  • December 2016 (1)
  • November 2016 (3)
  • October 2016 (3)
  • September 2016 (4)
  • August 2016 (2)
  • July 2016 (2)
  • June 2016 (5)
  • May 2016 (7)
  • April 2016 (4)
  • March 2016 (1)
  • February 2016 (2)
  • December 2015 (2)
  • November 2015 (3)
  • October 2015 (2)
  • September 2015 (1)
  • July 2015 (4)
  • June 2015 (2)
  • April 2015 (3)
  • March 2015 (3)
  • February 2015 (2)
  • January 2015 (1)

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Privacy Policy
  • Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

icon-phone +44 (0)1252 417030

Quick Links

  • Real World Evidence
  • Global Real World Evidence
  • Additional Services
  • Privacy Policy
  • Contact Us

Twitter

Tweets by @SVMPharma

RSS Latest News

  • Alunbrig recommended by NICE for non-small-cell lung cancer February 15, 2019
  • Trajenta meets primary endpoint in CAROLINA trial February 15, 2019
  • Could AI predict survival of ovarian cancer patients? February 15, 2019
  • NICE changes its mind on Perjeta February 15, 2019
  • New Academy launched to fight osteoporosis February 15, 2019
  • Privacy Policy
  • Website Disclaimer
  • Sitemap
© 2016 SVMPharma Ltd. All rights reserved.